Endocrinology Medical News about Type 1 Diabetes

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Feasibility of Continuous Subcutaneous Insulin Infusion and Daily Supplemental Insulin Glargine Injection in Children with Type 1 Diabetes
Diabetes Technology & Therapeutics, 08/25/09

Alemzadeh R et al. – CSII therapy with or without daily insulin glargine improved glycemic control without changes in the rate of hypoglycemia and DKA, suggesting that this treatment regimen is feasible and may also prevent development of hyperglycemia and ketosis or even DKA.

<< Previous
Assessment of Patient-Reported Outcomes of Insulin Pen Devices...

Next >>
Accuracy and Reliability of Continuous Glucose Monitoring in...